nodes	percent_of_prediction	percent_of_DWPC	metapath
Antazoline—Phenytoin—epilepsy syndrome	0.594	1	CrCtD
Antazoline—Phenytoin—Primidone—epilepsy syndrome	0.0491	0.126	CrCrCtD
Antazoline—Phenytoin—Fosphenytoin—epilepsy syndrome	0.0491	0.126	CrCrCtD
Antazoline—Phenytoin—Phenobarbital—epilepsy syndrome	0.0362	0.0932	CrCrCtD
Antazoline—Oxaprozin—Phenytoin—epilepsy syndrome	0.0336	0.0866	CrCrCtD
Antazoline—Oxaprozin—Carbamazepine—epilepsy syndrome	0.031	0.08	CrCrCtD
Antazoline—Phenytoin—Carbamazepine—epilepsy syndrome	0.031	0.08	CrCrCtD
Antazoline—Modafinil—Fosphenytoin—epilepsy syndrome	0.0288	0.0743	CrCrCtD
Antazoline—Benzyl Benzoate—Fosphenytoin—epilepsy syndrome	0.0201	0.0517	CrCrCtD
Antazoline—Modafinil—Phenytoin—epilepsy syndrome	0.0197	0.0509	CrCrCtD
Antazoline—Modafinil—Carbamazepine—epilepsy syndrome	0.0182	0.047	CrCrCtD
Antazoline—Modafinil—Oxcarbazepine—epilepsy syndrome	0.0168	0.0433	CrCrCtD
Antazoline—Benzphetamine—Phenytoin—epilepsy syndrome	0.0148	0.0383	CrCrCtD
Antazoline—Benzyl Benzoate—Phenytoin—epilepsy syndrome	0.0138	0.0355	CrCrCtD
Antazoline—Diphenhydramine—Phenytoin—epilepsy syndrome	0.0132	0.034	CrCrCtD
Antazoline—Benzyl Benzoate—Carbamazepine—epilepsy syndrome	0.0127	0.0327	CrCrCtD
Antazoline—Bepridil—CACNA2D2—epilepsy syndrome	0.000273	0.0767	CrCbGaD
Antazoline—Bepridil—CACNA1A—epilepsy syndrome	0.000259	0.0727	CrCbGaD
Antazoline—Phenytoin—SCN8A—epilepsy syndrome	0.000197	0.0554	CrCbGaD
Antazoline—Bepridil—CACNA1H—epilepsy syndrome	0.000161	0.0454	CrCbGaD
Antazoline—Phenytoin—SCN9A—epilepsy syndrome	0.00016	0.0448	CrCbGaD
Antazoline—Phenytoin—SCN3A—epilepsy syndrome	0.000153	0.0429	CrCbGaD
Antazoline—Bepridil—CACNA1D—epilepsy syndrome	0.000152	0.0428	CrCbGaD
Antazoline—Phenytoin—SCN4A—epilepsy syndrome	0.000147	0.0412	CrCbGaD
Antazoline—Phentolamine—ADRA2A—epilepsy syndrome	0.00014	0.0394	CrCbGaD
Antazoline—Diphenidol—CHRM3—epilepsy syndrome	0.000124	0.0348	CrCbGaD
Antazoline—Diphenidol—CHRM1—epilepsy syndrome	0.000116	0.0325	CrCbGaD
Antazoline—Naphazoline—ADRA2A—epilepsy syndrome	0.000114	0.0321	CrCbGaD
Antazoline—Trimethaphan—BCHE—epilepsy syndrome	0.000108	0.0302	CrCbGaD
Antazoline—Phenytoin—SCN1A—epilepsy syndrome	0.000107	0.0301	CrCbGaD
Antazoline—Phenytoin—SCN2A—epilepsy syndrome	9.45e-05	0.0265	CrCbGaD
Antazoline—Diphenidol—CHRM2—epilepsy syndrome	9.44e-05	0.0265	CrCbGaD
Antazoline—Dextropropoxyphene—OPRD1—epilepsy syndrome	9.39e-05	0.0264	CrCbGaD
Antazoline—Fentanyl—OPRD1—epilepsy syndrome	9.29e-05	0.0261	CrCbGaD
Antazoline—Tolazoline—ADRA2A—epilepsy syndrome	8.26e-05	0.0232	CrCbGaD
Antazoline—Dextropropoxyphene—OPRM1—epilepsy syndrome	7.19e-05	0.0202	CrCbGaD
Antazoline—Fentanyl—OPRM1—epilepsy syndrome	7.11e-05	0.02	CrCbGaD
Antazoline—Methadone—OPRD1—epilepsy syndrome	6.37e-05	0.0179	CrCbGaD
Antazoline—Tripelennamine—CYP2D6—epilepsy syndrome	4.96e-05	0.0139	CrCbGaD
Antazoline—Methadone—OPRM1—epilepsy syndrome	4.87e-05	0.0137	CrCbGaD
Antazoline—Aprindine—CYP2D6—epilepsy syndrome	4.84e-05	0.0136	CrCbGaD
Antazoline—Phenytoin—ABCC2—epilepsy syndrome	4.84e-05	0.0136	CrCbGaD
Antazoline—Oxaprozin—PTGS2—epilepsy syndrome	4.56e-05	0.0128	CrCbGaD
Antazoline—Benzphetamine—ADRA2A—epilepsy syndrome	4.55e-05	0.0128	CrCbGaD
Antazoline—Phenoxybenzamine—ADRA2A—epilepsy syndrome	4.35e-05	0.0122	CrCbGaD
Antazoline—Diphenhydramine—CHRM2—epilepsy syndrome	4.27e-05	0.012	CrCbGaD
Antazoline—Modafinil—CYP2C19—epilepsy syndrome	3.8e-05	0.0107	CrCbGaD
Antazoline—HRH1—GPCR ligand binding—CHRM3—epilepsy syndrome	3.75e-05	0.00267	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—BDKRB2—epilepsy syndrome	3.74e-05	0.00267	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—ACKR4—epilepsy syndrome	3.7e-05	0.00264	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—SSTR4—epilepsy syndrome	3.69e-05	0.00263	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—SSTR5—epilepsy syndrome	3.69e-05	0.00263	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—CNR1—epilepsy syndrome	3.67e-05	0.00262	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CX3CR1—epilepsy syndrome	3.59e-05	0.00256	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—epilepsy syndrome	3.58e-05	0.00255	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CCR10—epilepsy syndrome	3.53e-05	0.00252	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CHRM2—epilepsy syndrome	3.52e-05	0.00251	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CX3CL1—epilepsy syndrome	3.52e-05	0.00251	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—BDKRB1—epilepsy syndrome	3.52e-05	0.00251	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—epilepsy syndrome	3.49e-05	0.00249	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—GABBR1—epilepsy syndrome	3.43e-05	0.00244	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR2—epilepsy syndrome	3.41e-05	0.00243	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—SST—epilepsy syndrome	3.41e-05	0.00243	CbGpPWpGaD
Antazoline—Phenytoin—CYP2C19—epilepsy syndrome	3.37e-05	0.00946	CrCbGaD
Antazoline—HRH1—Signaling by GPCR—SSTR5—epilepsy syndrome	3.35e-05	0.00239	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—SSTR4—epilepsy syndrome	3.35e-05	0.00239	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—epilepsy syndrome	3.34e-05	0.00238	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—HRH3—epilepsy syndrome	3.28e-05	0.00234	CbGpPWpGaD
Antazoline—HRH1—G alpha (q) signalling events—HTR2A—epilepsy syndrome	3.25e-05	0.00231	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—OPRM1—epilepsy syndrome	3.23e-05	0.0023	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCR10—epilepsy syndrome	3.21e-05	0.00229	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL12—epilepsy syndrome	3.21e-05	0.00228	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—epilepsy syndrome	3.21e-05	0.00228	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR1—epilepsy syndrome	3.15e-05	0.00224	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—GRM2—epilepsy syndrome	3.09e-05	0.0022	CbGpPWpGaD
Antazoline—HRH1—G alpha (q) signalling events—AGT—epilepsy syndrome	3.08e-05	0.0022	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—epilepsy syndrome	3.07e-05	0.00219	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CCR3—epilepsy syndrome	3.05e-05	0.00218	CbGpPWpGaD
Antazoline—Bepridil—CYP2D6—epilepsy syndrome	2.99e-05	0.00841	CrCbGaD
Antazoline—HRH1—GPCR ligand binding—NPY—epilepsy syndrome	2.98e-05	0.00212	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—epilepsy syndrome	2.9e-05	0.00207	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—OXT—epilepsy syndrome	2.87e-05	0.00205	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CRH—epilepsy syndrome	2.87e-05	0.00205	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CXCL2—epilepsy syndrome	2.87e-05	0.00205	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CCL3—epilepsy syndrome	2.87e-05	0.00205	CbGpPWpGaD
Antazoline—HRH1—IL-4 Signaling Pathway—AKT1—epilepsy syndrome	2.81e-05	0.002	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—GRM2—epilepsy syndrome	2.8e-05	0.002	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—SSTR3—epilepsy syndrome	2.79e-05	0.00199	CbGpPWpGaD
Antazoline—Dextropropoxyphene—CYP2D6—epilepsy syndrome	2.78e-05	0.00782	CrCbGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—epilepsy syndrome	2.76e-05	0.00196	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CCR8—epilepsy syndrome	2.68e-05	0.00191	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—SSTR1—epilepsy syndrome	2.68e-05	0.00191	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—ARHGEF9—epilepsy syndrome	2.68e-05	0.00191	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CCR9—epilepsy syndrome	2.68e-05	0.00191	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—NPY2R—epilepsy syndrome	2.68e-05	0.00191	CbGpPWpGaD
Antazoline—Diphenhydramine—CYP2C19—epilepsy syndrome	2.64e-05	0.00741	CrCbGaD
Antazoline—HRH1—GPCR downstream signaling—GRM3—epilepsy syndrome	2.63e-05	0.00187	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—GRM4—epilepsy syndrome	2.63e-05	0.00187	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—SST—epilepsy syndrome	2.6e-05	0.00185	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CCR2—epilepsy syndrome	2.6e-05	0.00185	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—AVP—epilepsy syndrome	2.58e-05	0.00184	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—SSTR2—epilepsy syndrome	2.58e-05	0.00184	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—epilepsy syndrome	2.56e-05	0.00183	CbGpPWpGaD
Antazoline—Methadone—CYP2C19—epilepsy syndrome	2.55e-05	0.00715	CrCbGaD
Antazoline—HRH1—GPCR ligand binding—ADRA2A—epilepsy syndrome	2.54e-05	0.00181	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—SSTR3—epilepsy syndrome	2.54e-05	0.00181	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—epilepsy syndrome	2.54e-05	0.00181	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—epilepsy syndrome	2.51e-05	0.00179	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PRICKLE1—epilepsy syndrome	2.5e-05	0.00178	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PRDM4—epilepsy syndrome	2.5e-05	0.00178	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—GRM8—epilepsy syndrome	2.49e-05	0.00177	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CXCL12—epilepsy syndrome	2.44e-05	0.00174	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—BDKRB2—epilepsy syndrome	2.44e-05	0.00174	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—ARHGEF9—epilepsy syndrome	2.43e-05	0.00173	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCR8—epilepsy syndrome	2.43e-05	0.00173	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—SSTR1—epilepsy syndrome	2.43e-05	0.00173	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCR9—epilepsy syndrome	2.43e-05	0.00173	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—NPY2R—epilepsy syndrome	2.43e-05	0.00173	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CNR1—epilepsy syndrome	2.4e-05	0.00171	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—GRM3—epilepsy syndrome	2.38e-05	0.0017	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—GRM4—epilepsy syndrome	2.38e-05	0.0017	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—OPRD1—epilepsy syndrome	2.38e-05	0.00169	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—SSTR2—epilepsy syndrome	2.34e-05	0.00167	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—HTR7—epilepsy syndrome	2.34e-05	0.00167	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—GRM1—epilepsy syndrome	2.28e-05	0.00162	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CHRM1—epilepsy syndrome	2.28e-05	0.00162	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CCR7—epilepsy syndrome	2.28e-05	0.00162	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PDYN—epilepsy syndrome	2.28e-05	0.00162	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—GRM8—epilepsy syndrome	2.26e-05	0.00161	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	2.2e-05	0.00157	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ACKR4—epilepsy syndrome	2.19e-05	0.00156	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—GNAO1—epilepsy syndrome	2.16e-05	0.00154	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—OPRD1—epilepsy syndrome	2.16e-05	0.00154	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	2.15e-05	0.00153	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—GAL—epilepsy syndrome	2.14e-05	0.00153	CbGpPWpGaD
Antazoline—Bepridil—ABCB1—epilepsy syndrome	2.14e-05	0.006	CrCbGaD
Antazoline—HRH1—GPCR downstream signaling—GRM5—epilepsy syndrome	2.12e-05	0.00151	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CHRM3—epilepsy syndrome	2.12e-05	0.00151	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—GRM1—epilepsy syndrome	2.07e-05	0.00147	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PDYN—epilepsy syndrome	2.07e-05	0.00147	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCR7—epilepsy syndrome	2.07e-05	0.00147	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CHRM1—epilepsy syndrome	2.07e-05	0.00147	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	2.04e-05	0.00145	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—BDKRB1—epilepsy syndrome	1.99e-05	0.00142	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CHRM2—epilepsy syndrome	1.99e-05	0.00142	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—SSTR4—epilepsy syndrome	1.98e-05	0.00141	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—SSTR5—epilepsy syndrome	1.98e-05	0.00141	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—AVP—epilepsy syndrome	1.97e-05	0.0014	CbGpPWpGaD
Antazoline—Fentanyl—ABCB1—epilepsy syndrome	1.97e-05	0.00552	CrCbGaD
Antazoline—Diphenhydramine—CYP2D6—epilepsy syndrome	1.95e-05	0.00549	CrCbGaD
Antazoline—HRH1—Signaling by GPCR—GAL—epilepsy syndrome	1.94e-05	0.00139	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—GABBR1—epilepsy syndrome	1.94e-05	0.00138	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—GRM5—epilepsy syndrome	1.92e-05	0.00137	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CHRM3—epilepsy syndrome	1.92e-05	0.00137	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCR10—epilepsy syndrome	1.9e-05	0.00135	CbGpPWpGaD
Antazoline—Methadone—CYP2D6—epilepsy syndrome	1.89e-05	0.0053	CrCbGaD
Antazoline—Phenytoin—ALB—epilepsy syndrome	1.87e-05	0.00525	CrCbGaD
Antazoline—HRH1—GPCR downstream signaling—HRH3—epilepsy syndrome	1.86e-05	0.00132	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CX3CR1—epilepsy syndrome	1.84e-05	0.00131	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—OPRM1—epilepsy syndrome	1.83e-05	0.0013	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—BDKRB1—epilepsy syndrome	1.81e-05	0.00129	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CHRM2—epilepsy syndrome	1.81e-05	0.00129	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CX3CL1—epilepsy syndrome	1.81e-05	0.00129	CbGpPWpGaD
Antazoline—Phenytoin—ABCB1—epilepsy syndrome	1.78e-05	0.00501	CrCbGaD
Antazoline—HRH1—Signaling by GPCR—GABBR1—epilepsy syndrome	1.76e-05	0.00125	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CCR3—epilepsy syndrome	1.73e-05	0.00123	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	1.72e-05	0.00122	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—HRH3—epilepsy syndrome	1.69e-05	0.0012	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—NPY—epilepsy syndrome	1.68e-05	0.0012	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	1.68e-05	0.0012	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CCR5—epilepsy syndrome	1.67e-05	0.00119	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—OPRM1—epilepsy syndrome	1.66e-05	0.00118	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GRM2—epilepsy syndrome	1.66e-05	0.00118	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—HTR2A—epilepsy syndrome	1.64e-05	0.00117	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CXCL2—epilepsy syndrome	1.62e-05	0.00116	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CRH—epilepsy syndrome	1.62e-05	0.00116	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—OXT—epilepsy syndrome	1.62e-05	0.00116	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCR3—epilepsy syndrome	1.57e-05	0.00112	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—AGT—epilepsy syndrome	1.55e-05	0.00111	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—NPY—epilepsy syndrome	1.53e-05	0.00109	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—SSTR3—epilepsy syndrome	1.5e-05	0.00107	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CRH—epilepsy syndrome	1.47e-05	0.00105	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CXCL2—epilepsy syndrome	1.47e-05	0.00105	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—OXT—epilepsy syndrome	1.47e-05	0.00105	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCL3—epilepsy syndrome	1.47e-05	0.00105	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—SST—epilepsy syndrome	1.47e-05	0.00105	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CCR2—epilepsy syndrome	1.47e-05	0.00105	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ST3GAL3—epilepsy syndrome	1.47e-05	0.00105	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ARHGEF9—epilepsy syndrome	1.44e-05	0.00102	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NPY2R—epilepsy syndrome	1.44e-05	0.00102	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCR8—epilepsy syndrome	1.44e-05	0.00102	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—SSTR1—epilepsy syndrome	1.44e-05	0.00102	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCR9—epilepsy syndrome	1.44e-05	0.00102	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	1.44e-05	0.00102	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GRM4—epilepsy syndrome	1.41e-05	0.001	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GRM3—epilepsy syndrome	1.41e-05	0.001	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—DUSP4—epilepsy syndrome	1.38e-05	0.000986	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—SSTR2—epilepsy syndrome	1.38e-05	0.000986	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CXCL12—epilepsy syndrome	1.38e-05	0.000983	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	1.38e-05	0.000983	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CNR1—epilepsy syndrome	1.35e-05	0.000965	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PLCB1—epilepsy syndrome	1.35e-05	0.000962	CbGpPWpGaD
Antazoline—Methadone—ABCB1—epilepsy syndrome	1.35e-05	0.00379	CrCbGaD
Antazoline—HRH1—Signaling Pathways—GRM8—epilepsy syndrome	1.34e-05	0.000952	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PGF—epilepsy syndrome	1.34e-05	0.000952	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCR2—epilepsy syndrome	1.33e-05	0.00095	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—SST—epilepsy syndrome	1.33e-05	0.00095	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—HTR7—epilepsy syndrome	1.32e-05	0.000942	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—POMC—epilepsy syndrome	1.31e-05	0.000932	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—ADRA2A—epilepsy syndrome	1.3e-05	0.000929	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CCL2—epilepsy syndrome	1.28e-05	0.000912	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GNAO1—epilepsy syndrome	1.27e-05	0.000908	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—OPRD1—epilepsy syndrome	1.27e-05	0.000908	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—AKT3—epilepsy syndrome	1.26e-05	0.000897	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CXCL12—epilepsy syndrome	1.25e-05	0.000893	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—BDKRB2—epilepsy syndrome	1.25e-05	0.000893	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CNR1—epilepsy syndrome	1.23e-05	0.000876	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PLCB1—epilepsy syndrome	1.23e-05	0.000873	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GRM1—epilepsy syndrome	1.22e-05	0.000871	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCR7—epilepsy syndrome	1.22e-05	0.000871	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CHRM1—epilepsy syndrome	1.22e-05	0.000871	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PDYN—epilepsy syndrome	1.22e-05	0.000871	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—HTR7—epilepsy syndrome	1.2e-05	0.000855	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—HBEGF—epilepsy syndrome	1.16e-05	0.00083	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CDC42—epilepsy syndrome	1.15e-05	0.000819	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GAL—epilepsy syndrome	1.15e-05	0.000819	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GFAP—epilepsy syndrome	1.15e-05	0.000819	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—AKT3—epilepsy syndrome	1.14e-05	0.000815	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GRM5—epilepsy syndrome	1.14e-05	0.000809	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CASP2—epilepsy syndrome	1.14e-05	0.000809	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CHRM3—epilepsy syndrome	1.14e-05	0.000809	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—AVP—epilepsy syndrome	1.11e-05	0.000793	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CX3CR1—epilepsy syndrome	1.09e-05	0.000776	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CHRM2—epilepsy syndrome	1.07e-05	0.000761	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—BDKRB1—epilepsy syndrome	1.07e-05	0.000761	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CX3CL1—epilepsy syndrome	1.07e-05	0.000761	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CDC42—epilepsy syndrome	1.04e-05	0.000743	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GABBR1—epilepsy syndrome	1.04e-05	0.00074	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—AVP—epilepsy syndrome	1.01e-05	0.00072	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HRH3—epilepsy syndrome	9.96e-06	0.00071	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—OPRM1—epilepsy syndrome	9.8e-06	0.000699	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CCR5—epilepsy syndrome	9.46e-06	0.000674	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCR3—epilepsy syndrome	9.26e-06	0.00066	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—HTR2A—epilepsy syndrome	9.25e-06	0.000659	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ATP2A2—epilepsy syndrome	9.02e-06	0.000643	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NPY—epilepsy syndrome	9.02e-06	0.000643	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—AGT—epilepsy syndrome	8.78e-06	0.000626	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HSPB1—epilepsy syndrome	8.7e-06	0.00062	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CRH—epilepsy syndrome	8.7e-06	0.00062	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—OXT—epilepsy syndrome	8.7e-06	0.00062	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CXCL2—epilepsy syndrome	8.7e-06	0.00062	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCL3—epilepsy syndrome	8.7e-06	0.00062	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCR5—epilepsy syndrome	8.59e-06	0.000612	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—HTR2A—epilepsy syndrome	8.4e-06	0.000599	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PRKCB—epilepsy syndrome	8.11e-06	0.000578	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—TSC1—epilepsy syndrome	8.09e-06	0.000577	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PTK2B—epilepsy syndrome	8.09e-06	0.000577	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—AGT—epilepsy syndrome	7.97e-06	0.000568	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCR2—epilepsy syndrome	7.87e-06	0.000561	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—SST—epilepsy syndrome	7.87e-06	0.000561	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NTRK2—epilepsy syndrome	7.87e-06	0.000561	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—DUSP6—epilepsy syndrome	7.8e-06	0.000556	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ADRA2A—epilepsy syndrome	7.7e-06	0.000549	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PLAT—epilepsy syndrome	7.67e-06	0.000547	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—BDKRB2—epilepsy syndrome	7.4e-06	0.000527	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CXCL12—epilepsy syndrome	7.4e-06	0.000527	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—POMC—epilepsy syndrome	7.39e-06	0.000527	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PRKCB—epilepsy syndrome	7.37e-06	0.000525	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—IL6ST—epilepsy syndrome	7.34e-06	0.000523	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—JUNB—epilepsy syndrome	7.26e-06	0.000518	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CNR1—epilepsy syndrome	7.26e-06	0.000518	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PLCB1—epilepsy syndrome	7.24e-06	0.000516	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HTR7—epilepsy syndrome	7.09e-06	0.000505	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HBEGF—epilepsy syndrome	6.88e-06	0.00049	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—AKT3—epilepsy syndrome	6.75e-06	0.000481	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—POMC—epilepsy syndrome	6.71e-06	0.000478	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ADAM10—epilepsy syndrome	6.6e-06	0.00047	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCL2—epilepsy syndrome	6.57e-06	0.000468	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—S100B—epilepsy syndrome	6.24e-06	0.000445	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—SOCS3—epilepsy syndrome	6.18e-06	0.00044	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CDC42—epilepsy syndrome	6.16e-06	0.000439	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—AVP—epilepsy syndrome	5.97e-06	0.000425	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HES1—epilepsy syndrome	5.64e-06	0.000402	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—FYN—epilepsy syndrome	5.49e-06	0.000391	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—H2AFX—epilepsy syndrome	5.47e-06	0.00039	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—MEF2C—epilepsy syndrome	5.46e-06	0.000389	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	5.27e-06	0.000376	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NGF—epilepsy syndrome	5.21e-06	0.000372	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	5.07e-06	0.000361	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	4.96e-06	0.000354	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	4.72e-06	0.000336	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—AGT—epilepsy syndrome	4.71e-06	0.000336	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—APOE—epilepsy syndrome	4.61e-06	0.000329	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—KDR—epilepsy syndrome	4.52e-06	0.000322	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	4.35e-06	0.00031	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	4.33e-06	0.000309	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—POMC—epilepsy syndrome	3.96e-06	0.000283	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	3.88e-06	0.000276	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	3.51e-06	0.00025	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—RELA—epilepsy syndrome	3.25e-06	0.000232	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	3.19e-06	0.000227	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	2.96e-06	0.000211	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	2.94e-06	0.000209	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—JUN—epilepsy syndrome	2.85e-06	0.000203	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	2.77e-06	0.000198	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	2.69e-06	0.000192	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—SRC—epilepsy syndrome	2.56e-06	0.000182	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	2.49e-06	0.000178	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	1.59e-06	0.000113	CbGpPWpGaD
